multiple aetiologies, though in practice the vast majority of HF occurs after pathological insult to the heart (chronic pressure overload, myocardial infarction, or metabolic disease, for example), and develops from the maladaptive responses to these insults. 3 This current paradigm, advanced by basic and translational research, that the adult HF syndrome arises from a common pathological remodelling response to these varied stresses, has paved the way for successful clinical trials studying broad populations of HF patients, generally without regard to the causative nature of the syndrome. These clinical trials represent great successes of evidence-based medicine and came to fruition, in part, by drawing on a large base of epidemiological and physiological research in adults.
In stark contrast, HF in children differs in prevalence, in both absolute and relative numbers, from adult HF. 4 Importantly, the aetiologies of HF differ between adults, in which coronary artery disease accounts for the largest proportion of cardiomyopathy, and children, in which congenital heart conditions have a much higher prevalence, and coronary disease remains rare. Furthermore, HF in children can occur at ages ranging from infancy to early adulthood, and therefore may have different pathophysiological effects during these varied stages of active growth and development.
For these and other reasons, clinicians hesitate to apply adult HF therapies and guidelines to paediatric populations. The varied epidemiology and unique challenges in paediatric HF populations described above have also limited the opportunities for clinical investigation in this population. 4, 5 Specifically, the haemodynamic profiles of children with HF, and how these relate to outcomes, symptoms, and organ function, remain poorly studied and represent important knowledge gaps in the field. In this issue of European Heart Journal, 6 Chen and colleagues have therefore taken an important step by studying the haemodynamic features specific to children with end-stage HF listed for heart transplant, for which clinical data and guidelines remain particularly sparse. 7 The investigators specifically analyzed the Paediatric Heart
Transplant Study database, a large international registry, to investigate the association of haemodynamic profiles with other clinical variables and outcomes. The major findings of the study are that: (i) elevated left-sided filling pressures are highly prevalent in this population and (ii) elevations in pulmonary capillary wedge pressure chiefly predict clinical outcomes and clinical deterioration in this population, whereas decreased cardiac output appears less strongly associated with ultimate change in clinical status. Specifically, their multivariate analysis identified that congestion, as opposed to decreased cardiac output, predicted the severity of symptoms, clinical outcomes, worsening clinical status, and abnormalities of markers of renal and hepatic function. Although the combination of low cardiac output and left-sided congestion predicted worsening outcomes, isolated congestion, but not isolated low output, independently predicted death or clinical deterioration. In other words, reverse or 'warm' HF both occurred more frequently and better predicted prognosis than forward or 'cold' HF ( Figure 1 ). This study represents the largest effort to date to examine haemodynamics in paediatric patients with end-stage HF. This is of particular importance due to the relative lack of data in the field. Further, the population in this well-designed study encompassed a broad range of HF aetiologies and patient ages, comparable to the populations reflected in clinical practice. 4 In addition to representing a critical piece of data in an understudied area, this work also identifies elevation in cardiac filling pressures as potentially more important in the pathophysiology of late-stage HF than previously recognized in children. 8 As the authors appropriately acknowledge, care must be taken not to over-interpret these new findings, owing to the standard limitations of any observational study. For example, the authors note the potential for selection bias in their data, in which patients receiving invasive haemodynamic assessment may have had unique characteristics compared with the high number of patients in the database not receiving haemodynamic monitoring (or, for that matter, compared with those patients with end-stage HF not listed for transplant). Additionally, the degree to which congestion represents a cause of organ dysfunction and poor outcomes vs. serving simply as a marker of these pathologies cannot be determined from these observed associations.
But, like all strong translational research, this work identifies a number of important new scientific and clinical questions. From the physiological perspective, why does congestion potentially contribute to adverse outcomes in young patients, and why has this phenomenon been less recognized in paediatric populations compared with adults? 8 Further, what is the pathophysiological effect of congestion on development and growth, and might this have different biological ramifications in paediatric vs. (typically elderly) adult populations? From the clinical perspective, what is the applicability of these findings to the broader population of children with HF? If future studies confirm the high prevalence and prognostic value of congestion in paediatric HF patients, it will be important to investigate whether non-invasive techniques to estimate filling pressures, such as Doppler echocardiography, can provide the same degree of prognostic value. What do these findings tell us about the potential refined role of invasive haemodynamic testing in the workup and assessment of children with HF?
It should be possible to address these important questions in the near future. And, when answered, perhaps they will help refine the paradigm of paediatric HF from 'not just small adults' to a more evidence-based and haemodynamically-tailored approach. 
